Haleon plc (NYSE:HLN) Shares Sold by AIMZ Investment Advisors LLC

AIMZ Investment Advisors LLC reduced its stake in shares of Haleon plc (NYSE:HLN) by 3.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 70,552 shares of the company’s stock after selling 2,200 shares during the quarter. AIMZ Investment Advisors LLC’s holdings in Haleon were worth $673,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Fortitude Family Office LLC purchased a new stake in Haleon during the third quarter worth $28,000. Sierra Ocean LLC acquired a new position in shares of Haleon during the 4th quarter worth $26,000. Versant Capital Management Inc boosted its position in shares of Haleon by 2,029.1% in the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after buying an additional 3,348 shares in the last quarter. Toronto Dominion Bank boosted its position in shares of Haleon by 3,470.0% in the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares in the last quarter. Finally, Geneos Wealth Management Inc. acquired a new stake in Haleon in the 4th quarter valued at about $35,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HLN has been the topic of several research reports. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Haleon has a consensus rating of “Moderate Buy” and an average price target of $10.95.

Haleon Trading Down 3.9 %

Shares of HLN stock opened at $9.81 on Friday. The firm’s 50-day simple moving average is $9.59 and its 200-day simple moving average is $9.83. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80. The firm has a market cap of $44.39 billion, a P/E ratio of 28.84, a PEG ratio of 2.82 and a beta of 0.28.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, equities analysts forecast that Haleon plc will post 0.43 EPS for the current year.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.